Package 10135-822-90

{"route": ["ORAL"], "spl_id": "387ce260-7ac6-36e8-e063-6394a90a4e49", "openfda": {"unii": ["ZB22ENF0XR"], "rxcui": ["1874553", "1874559"], "spl_set_id": ["387cea91-6924-2a68-e063-6394a90a8f75"], "manufacturer_name": ["Marlex Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-822-10)", "package_ndc": "10135-822-10", "marketing_start_date": "20250701"}, {"sample": false, "description": "14 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-822-14)", "package_ndc": "10135-822-14", "marketing_start_date": "20250701"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-822-30)", "package_ndc": "10135-822-30", "marketing_start_date": "20250701"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-822-90)", "package_ndc": "10135-822-90", "marketing_start_date": "20250701"}], "brand_name": "Desvenlafaxine", "product_id": "10135-822_387ce260-7ac6-36e8-e063-6394a90a4e49", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "product_ndc": "10135-822", "generic_name": "Desvenlafaxine", "labeler_name": "Marlex Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Desvenlafaxine", "active_ingredients": [{"name": "DESVENLAFAXINE SUCCINATE", "strength": "100 mg/1"}], "application_number": "ANDA204805", "marketing_category": "ANDA", "marketing_start_date": "20250701", "listing_expiration_date": "20261231"}